Physician profile
Felix E Gonzales
NPI 1326006131
$1,888.19
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $367 · 2021: $1,089 · 2022: $133.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $630.84 | 2021 | |
| Acclarent, INC | $444.21 | 2019-2022 | |
| Intersect Ent, INC. | $307.55 | 2020-2021 | |
| Stryker Corporation | $162.45 | 2019-2022 | |
| Karl Storz Endoscopy-America | $91.31 | 2020-2021 | |
| Aerin Medical INC. | $66.41 | 2021 | |
| Glaxosmithkline, LLC. | $60.35 | 2021-2022 | |
| Smith+Nephew, INC. | $46.86 | 2021-2022 | |
| Olympus America INC. | $18.11 | 2020 | |
| Medtronic, INC. | $14.15 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.05 | 2020 | |
| Alk-Abello, INC | $11.58 | 2020 | |
| Medtronic USA, INC. | $11.42 | 2019 | |
| Genzyme Corporation | $10.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Gonzales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.